Ann: Trading Halt, page-38

NOVONIX Limited (‘NOVONIX or ‘Company’) is intending to undertake acapital raising comprising: ·
Approximately $115 million fully underwritten placementinstitutional and sophisticated investors (‘Institutional Placement’);·

A non-underwritten Share Purchase Plan (‘SPP’) to raise approximately $15 million; and·
Subject to shareholder approval, a non-underwritten placement of new shares to each of the following directors to raise approximately $16.45 million:Mr Trevor St Baker AO – $12 million;Mr Andrew N Liveris AO – $3 million;Admiral Robert J Natter – $1.25 million; andMr Robert Cooper – $200,000 (together the ‘Conditional Placements’)

Together, the Intuitional Placement, SPP and Conditional Placements are referred to as the Capital Raising (‘Capital Raising’). Morgansis a participating broker and has no formal role in the Capital Raising. The price of $2.90 per New Share, represents:
Issue price of $2.90 per new share, representing a 11.9% discount to the closing price of NOVONIX shares of $3.29 on 24 February 2021.

Use of Proceeds Funds raised will provide capex and working capital to scale production for NOVONIX Anode Materials, fund R&D in cathode and other advanced battery technologies, fund general corporate costs and provide flexibility to pursue international growth opportunities.The Capital Raising will allow NOVONIX to fund capex to increase production of NOVONIX Anode Materials to 10,000 tonnes per annum.

Share Purchase Plan Shareholders on the NOVONIX register at 7:00pm (Sydney time) on 24 February 2021 (Record Date) with a registered address in Australia or New Zealand will be entitled to subscribe for up to $10,000 worth of NOVONIX shares per shareholder.